Skip to main content
Genic Co.,Ltd logo

Genic Co.,Ltd — Investor Relations & Filings

Ticker · 123330 ISIN · KR7123330003 LEI · 988400OK43D3RRZEVD71 KO Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2021-12-01 Delisting Announcement
Country KR South Korea
Listing KO 123330

About Genic Co.,Ltd

http://www.genic21.com/en/index.asp

Genic Co., Ltd. is a cosmetics and pharmaceuticals company specializing in the research, development, and manufacturing of skincare products. As a prominent Original Design Manufacturer (ODM), the company is a major producer of facial masks and is recognized for pioneering hydrogel mask technology based on its proprietary patents. Its product portfolio includes a range of masks, eye patches, creams, emulsions, toners, and cleansing gels. Genic focuses on innovation through advanced biotechnology with a commitment to promoting 'healthy beauty'.

Recent filings

Filing Released Lang Actions
해산사유발생(종속회사의주요경영사항)
Delisting Announcement Classification · 1% confidence The document is a regulatory filing from a Korean company (Genic) regarding the dissolution of a subsidiary (Genic Shanghai Cosmetics). It details the reason for dissolution (COVID-19 impact, business environment), the decision date, and financial impact on the parent company. This falls under general regulatory announcements regarding material corporate events that do not fit into specific categories like M&A, dividends, or director dealings, thus it is classified as a Regulatory Filing (RNS).
2021-12-01 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Genic Co., Ltd.' covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding changes of Credit Suisse Group AG in the company 'Genic' (주식회사 제닉). This type of document is a mandatory disclosure to financial regulators regarding significant ownership stakes and is classified under 'Major Shareholding Notification'.
2021-09-13 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Genic' covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-12 Korean
[기재정정]반기보고서 (2021.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Genic' (주식회사 제닉) covering the period from January 1, 2021, to June 30, 2021. It includes detailed financial information, corporate governance details, board activities, and management discussions. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-12 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Genic Co., Ltd.' covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, management discussion, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.